Nova Eye (Australia) Odds of Future Stock Price Finishing Under 0.19
| EYE Stock | 0.15 0.01 6.25% |
Nova |
Nova Eye Target Price Odds to finish below 0.19
The tendency of Nova Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 0.19 after 90 days |
| 0.15 | 90 days | 0.19 | about 68.18 |
Based on a normal probability distribution, the odds of Nova Eye to stay under 0.19 after 90 days from now is about 68.18 (This Nova Eye Medical probability density function shows the probability of Nova Stock to fall within a particular range of prices over 90 days) . Probability of Nova Eye Medical price to stay between its current price of 0.15 and 0.19 at the end of the 90-day period is about 60.64 .
Assuming the 90 days trading horizon Nova Eye Medical has a beta of -0.0234 suggesting as returns on the benchmark increase, returns on holding Nova Eye are expected to decrease at a much lower rate. During a bear market, however, Nova Eye Medical is likely to outperform the market. Additionally Nova Eye Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Nova Eye Price Density |
| Price |
Predictive Modules for Nova Eye
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nova Eye Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nova Eye Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nova Eye is not an exception. The market had few large corrections towards the Nova Eye's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nova Eye Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nova Eye within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.54 | |
β | Beta against Dow Jones | -0.02 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.14 |
Nova Eye Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nova Eye for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nova Eye Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nova Eye Medical generated a negative expected return over the last 90 days | |
| Nova Eye Medical has some characteristics of a very speculative penny stock | |
| Nova Eye Medical has high historical volatility and very poor performance | |
| The company reported the revenue of 23.32 M. Net Loss for the year was (8.79 M) with profit before overhead, payroll, taxes, and interest of 14.39 M. | |
| Nova Eye Medical has accumulated about 7.42 M in cash with (7.73 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Nova Eye Medical Discusses Future Expectations and Risks - TipRanks |
Nova Eye Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nova Stock often depends not only on the future outlook of the current and potential Nova Eye's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nova Eye's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 204.1 M | |
| Cash And Short Term Investments | 6.2 M |
Nova Eye Technical Analysis
Nova Eye's future price can be derived by breaking down and analyzing its technical indicators over time. Nova Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nova Eye Medical. In general, you should focus on analyzing Nova Stock price patterns and their correlations with different microeconomic environments and drivers.
Nova Eye Predictive Forecast Models
Nova Eye's time-series forecasting models is one of many Nova Eye's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nova Eye's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Nova Eye Medical
Checking the ongoing alerts about Nova Eye for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nova Eye Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nova Eye Medical generated a negative expected return over the last 90 days | |
| Nova Eye Medical has some characteristics of a very speculative penny stock | |
| Nova Eye Medical has high historical volatility and very poor performance | |
| The company reported the revenue of 23.32 M. Net Loss for the year was (8.79 M) with profit before overhead, payroll, taxes, and interest of 14.39 M. | |
| Nova Eye Medical has accumulated about 7.42 M in cash with (7.73 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Nova Eye Medical Discusses Future Expectations and Risks - TipRanks |
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.